CMI was significantly higher in women with invasive ductal carcinoma lacking an associated in situ component (p=0.05), tumors with higher Ki67 proliferation (p < 0.01), and larger tumor size (p < 0.04). The gene discussed is MKI67; the disease is invasive ductal breast carcinoma.